Latest stent ruling goes in Medtronic's favour
This article was originally published in Clinica
Executive Summary
The US District Court in Delaware has reversed an earlier ruling of patent infringement by two of Medtronic's metal stent designs, including the model used in the drug-eluting device it is developing. At the beginning of January, the same judge at the court had issued a summary judgement ruling of infringement by the S7 and Driver coronary stents of one claim of a US Guidant patent (see Clinica No 1140, p 13).